Modification-Dependent Activity Assays for Recombinant Polypeptides
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for measuring the activity of recombinant polypeptides, especially in the context of recombinant polypeptide therapy for diseases like hemophilia, are hindered by the interference of endogenous polypeptides, making it difficult to distinguish between administered and naturally occurring polypeptides.
Innovation Solution
The development of modification-dependent activity assays (MDAAs) that utilize a modification-recognizing capture agent to selectively bind to recombinant polypeptides with modifications such as PEGylation, polysialylation, or HESylation, allowing for the separation and detection of these polypeptides even in the presence of endogenous versions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional activity assays are used to measure recombinant polypeptide activity, then the assay can detect polypeptide activity in general, but the presence of endogenous polypeptides interferes with the specificity and accuracy of detection
Solution Approach 1:
The invention extracts and isolates the recombinant polypeptide from the complex biological sample by using a capture agent that specifically binds to the modification on the recombinant polypeptide. This extraction step separates the target analyte from interfering endogenous polypeptides, enabling accurate measurement without interference.
Solution Approach 2:
The capture agent acts as an intermediary that selectively recognizes and binds to the modification on the recombinant polypeptide. This intermediary molecule enables specific capture of the recombinant polypeptide while leaving endogenous polypeptides in solution, thereby resolving the interference problem.
2Measurement precision
If modification-dependent activity assays are implemented to achieve selective detection, then specificity is improved, but the assay procedure becomes more complex
Solution Approach 1:
The assay is divided into distinct sequential steps: capture step (incubation with capture agent), separation step (purification of bound complex), and detection step (activity measurement). This segmentation allows each step to be optimized independently and simplifies the overall procedure by making the selective capture mechanism the focus rather than attempting to achieve specificity through complex assay conditions.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
MDAAs enable accurate detection and measurement of recombinant polypeptide activity, overcoming interference from endogenous polypeptides and providing reliable assessment of therapeutic efficacy.
Implementation Method 1
incubating a sample including the recombinant polypeptide comprising the modification with a capture agent that selectively binds the modification under conditions allowing the selective binding of the capture agent to the modification, thereby forming a polypeptide-agent complex
Data Source
Figure 1~2
Figure 3~4
Figure 5~6
AI summary
Disclosed herein are methods, systems and kits to measure the presence and/or activity of recombinant polypeptides comprising a modification.